DMED Stock Overview
A digital health artificial intelligence company, engages in the development and commercialization of digital therapeutics for people suffering from mental health and neurological disorders. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Diagnamed Holdings Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.02 |
| 52 Week High | CA$0.07 |
| 52 Week Low | CA$0.005 |
| Beta | -4.05 |
| 11 Month Change | -20.00% |
| 3 Month Change | 33.33% |
| 1 Year Change | -33.33% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -66.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| DMED | CA Healthcare Services | CA Market | |
|---|---|---|---|
| 7D | 0% | 9.3% | 0.8% |
| 1Y | -33.3% | 113.4% | 22.3% |
Return vs Industry: DMED underperformed the Canadian Healthcare Services industry which returned 109.7% over the past year.
Return vs Market: DMED underperformed the Canadian Market which returned 22.2% over the past year.
Price Volatility
| DMED volatility | |
|---|---|
| DMED Average Weekly Movement | 77.9% |
| Healthcare Services Industry Average Movement | 9.9% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.6% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: DMED's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: DMED's weekly volatility has increased from 50% to 78% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Fabio Chianelli | www.diagnamed.com |
Diagnamed Holdings Corp., a digital health artificial intelligence company, engages in the development and commercialization of digital therapeutics for people suffering from mental health and neurological disorders. It focuses on CERVAI, a brain health AI platform; and Health GenAI, a suite of generative AI solutions for the healthcare market that includes OpenAI's ChatGPT. The company also develops Dr. GENAI, a personal AI medical chatbot designed to give people to obtain fast and personalized medical information based on a person’s unique medical condition.
Diagnamed Holdings Corp. Fundamentals Summary
| DMED fundamental statistics | |
|---|---|
| Market cap | CA$2.40m |
| Earnings (TTM) | -CA$610.02k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-2.6x
P/E RatioIs DMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DMED income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$610.02k |
| Earnings | -CA$610.02k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0076 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did DMED perform over the long term?
See historical performance and comparison